ZEN-3694
AssetAlso ZEN003694
Inhibits BET bromodomain proteins to regulate oncogenic gene transcription
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Epigenetic regulation of gene expression
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1NUT carcinoma
Phase 2, newsfilecorp.com, Oct 8, 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.